![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 34, 30968-30975, August 23, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
andFrom the Department of Biochemistry, Stanford University, Stanford, California 94305
Received for publication, April 3, 2002, and in revised form, May 17, 2002
| |
ABSTRACT |
|---|
|
|
|---|
Understanding protein conformation, interactions,
and ligand binding is essential to all biological inquiry. We report a
novel biochemical technique, called misincorporation proton-alkyl
exchange (MPAX), that can be used to footprint protein structure at
single amino acid resolution. MPAX exploits translational
misincorporation of cysteine residues to generate probes for physical
analysis. We apply MPAX to the triosephosphate isomerase
( To rapidly obtain functional information for a large number of
sequences, a general and efficient tool for probing protein conformation is required. In principle, protein footprinting
provides a means to study protein structure, but it has been
far less successful than the corresponding techniques developed for
nucleic acids (1). Because of the chemical heterogeneity of the amino
acid side chains, no reagent exists with the ability to cleave
uniformly the protein backbone under native conditions. Furthermore,
protein separation techniques such as SDS-PAGE do not possess the
single monomer resolution of the urea-acrylamide gels used for the
separation of nucleic acids, which complicates the analysis of observed
cleavage patterns. Finally, because of the cooperative nature of
protein unfolding, proteolytic cleavage at one site often leads to a
global loss of structure and to increased cleavage at other sites in the same molecule, resulting in artifactual data.
Footprinting by chemical modification of amino acid side chains
represents a different approach to the problem. Modification of
side chains is carried out under native conditions, whereas detection
of modifications can be performed under arbitrary conditions. The
susceptibility of each side chain to modification reports its solvent
accessibility. Acylation of lysine residues (2, 3), oxidation of
methionine residues (4), and alkylation of cysteine residues (5, 6)
have been used previously to footprint protein structures. These
studies have been limited in scope, however, because they examine only
a few naturally occurring residues or require extensive site-directed
mutagenesis to introduce additional structural probes. Here we
describe a new experimental approach, termed misincorporation
proton-alkyl exchange
(MPAX),1 that overcomes many
of the limitations of traditional protein footprinting and facilitates
high throughput analysis.
MPAX utilizes the sulfhydryl groups of cysteine residues as reactive
sites that can be modified specifically under native conditions.
Because cysteine residues occur naturally at a low frequency,
auxiliary cysteines must be introduced into a protein of
interest to act as structural probes. An expedient strategy for
introducing cysteine residues is to subvert the protein translational machinery. Recently, mutant bacterial cysteine tRNAs were created by
substituting the cysteine anti-codon triplet with an isoleucine or methionine anti-codon triplet (7). These tRNAs were
demonstrated to misincorporate cysteine at isoleucine and methionine
codons complementary to the mutant triplets. Based on this finding, we engineered anti-codon variants of the cysteine tRNA that substitute cysteine residues for a variety of other amino acids. These
misincorporator tRNAs are expressed from autonomous plasmids that can
be co-transformed with arbitrary protein expression vectors.
The MPAX strategy is outlined in Fig. 1.
Co-expression of a cysteine misincorporator tRNA with a protein of
interest in Escherichia coli results in cysteine being
misincorporated at low frequency for one type of amino acid. The
substituted proteins are exposed to a thiol-specific alkylating
reagent. The rate of alkylation at each misincorporated cysteine
provides a measurement of its solvent accessibility. Cysteine
alkylation is measured by mass spectrometry or by protection
from backbone cleavage by the cysteine-specific cutting
reagent 2-nitro-5-thiocyanobenzoic acid (NTCB) (8). Because
misincorporation occurs at a single amino acid type, cleavage sites are
generally distant in the sequence, and cleavage fragments can be
separated using SDS-PAGE. Combining data from separate gel lanes for
misincorporation at different amino acids overcomes the intrinsic
limitations of these gels and can provide structural information at
single amino acid resolution. Because typical misincorporation frequencies are ~1%/site, a very small fraction of proteins is expected to contain more than a single cysteine substitution. Rates of
modification at slowly reacting sites can be measured accurately
despite the existence of rapidly reacting sites, because the
misincorporated cysteines are located in different molecules. The
method is not limited by protein size or solubility and
requires only microgram quantities of material.
Misincorporation of Cysteine--
The E. coli
cysteine tRNA was cloned under the control of the T7 promoter of
the pET21a plasmid (Novagen, Madison, WI), and the E. coli cysteinyl tRNA synthetase was cloned into the
BglII and SphI sites of the same plasmid to
generate pMPAX. Derivative misincorporator plasmids were
generated by Kunkel mutagenesis (9) of the tRNA anti-codon
sequence and named pMPAXDNB(ABC), where ABC denotes the mutant
anti-codon triplet. A synthetic yeast TIM gene (10) was amplified by
PCR, adding a C-terminal protein kinase A tag (amino acid sequence:
GRRASIY), and cloned into the EcoRI and HindIII
sites of pET28a (Novagen). The two native cysteines were substituted by
Kunkel mutagenesis to generate the C41V/C126A double mutant
designated pH6_TIM_PKA. BL21(DE3) cells were co-transformed with pH6_TIM_PKA and the pMPAX derivative of interest. The
cultures were grown in M63 medium (11) containing 50 µg/ml ampicillin and 20 µg/ml kanamycin and induced overnight by the addition of isopropyl-1-thio- NTCB Cleavage--
Ten µg of purified protein was
radioactively labeled by incubation with
[ Substrate Binding--
Labeled protein misincorporated at
leucine or valine was incubated with or without 50 mM
sodium glyceraldehyde-3-phosphate in 200 mM sodium bicine,
pH 8.6, 10 mM iodoacetamide for 2 min before quenching and
cleavage. Illustrations were generated using MOLSCRIPT (16) and the
7TIM structure (17).
Antibody Binding--
The Myc epitope sequence (EQKLISEEDL) was
inserted at position 132 in the yeast TIM sequence by Kunkel
mutagenesis. The denatured protein was diluted from 5 M urea into a reaction containing a final
concentration of 1 M urea, 50 mM sodium bicine,
pH 8.6, 150 mM NaCl with or without 1 µl of polyclonal
anti-Myc serum and incubated with 10 mM iodoacetamide for 2 min.
Measurement of Protection Factors--
Labeled protein was
prepared and incubated for 24 h with 50 mM sodium
bicine, pH 8.6, 10 mM iodoacetamide. The samples were taken
at various time points, acid-quenched, and stored at Selection for Misincorporation--
The Helicobacter
pylori amidase AmiE was amplified from genomic DNA by PCR and
cloned between the BglII and SphI sites of pET24a (Novagen) to generate pAmiE. Mutations at
Cys165 were created by Kunkel mutagenesis. Mutant
pMPAX libraries were generated by treating 10 µg of pMPAX(GUG) or
pMPAX(GCU) DNA with ultraviolet light in a Stratalinker (Stratagene, La
Jolla, CA) for 30 s. The libraries were transformed into BL21(DE3)
Tuner cells (Novagen) containing pAmiE with either a C165S or a C165H mutation, resulting in 105-106 transformants.
pMPAX plasmids from cells that grew faster than the parent plasmid in
acetamide medium (50 mM potassium phosphate, pH 7.8, 10 mM glucose, 1 mM MgCl2, 100 µM citric acid, 50 µM FeCl3, 25 µM MnCl2, 25 µM
CaCl2, 100 mM acetamide, 25 µM
isopropyl-1-thio- Read-out by Mass Spectrometry--
Details of the
synthesis and characterization of the ICAT reagents are
provided as supplementary material upon request. Wild-type TIM was
incubated with 10 mM 13C-ICAT, 50 mM sodium bicine, pH 8.6, at room temperature for 10, 300, or 1440 min. 12C-ICAT was added to 100 mM,
followed by guanidinium chloride to 4 M, and the reactions
were incubated for 45 min. Two samples of wild-type TIM were treated
respectively with 100 mM of 13C-ICAT or
12C-ICAT in 100 mM sodium bicine, pH 8.6, 4 M guanidinium chloride for 1 h and then pooled to
generate a control sample with a 1:1 ratio of
12C:13C at each misincorporated cysteine. The
samples were trichloroacetic acid-precipitated to remove excess
alkylating reagents and resuspended in 5 M urea. The urea
was diluted to 0.5 M in 100 mM Tris chloride, pH 8.0, 25 µg/ml sequencing-grade trypsin (Roche Molecular
Biochemicals), and the protein was digested overnight at 37 °C. The
samples were clarified by centrifugation, and the supernatant was added
to 250 µl of phenylboronate acrylamide beads (Pierce)
pre-equilibrated in binding buffer (50 mM sodium HEPES, pH
9.0, 500 mM NaF, 10% acetonitrile). The mixture was
rotated for 30 min and then washed for three 30-min incubations with 1 ml of binding buffer. Modified peptides were eluted by two 15-min
incubations with 250 µl of elution buffer (10 mM Tris
chloride, pH 8.0, 100 mM sorbitol, 10% acetonitrile). The
eluates were pooled, concentrated under vacuum, and injected
onto a 1 × 50-mm C18 column (Michrom, Auburn, CA) in buffer A
(0.025% trifluoroacetic acid, 0.1% formic acid in water) and eluted
in a linear gradient of 5-70% buffer B (0.022% trifluoroacetic acid,
0.085% formic acid in acetonitrile) over 50 min. Eluting peptides were
analyzed by tandem mass spectrometry on an LCQ ion trap mass
spectrometer (ThermoFinnigan, San Jose, CA) at the Stanford Mass
Spectrometry Facility essentially as described in Ref. 19. No
difference in the elution times of the 13C-ICAT or
12C-ICAT modified peptides was observed. The entire peak
area was integrated for calculation of the mass ratio.
Demonstration of Misincorporation--
A cysteine-free variant of
yeast TIM was used as a model system to investigate the MPAX technique.
TIM is a dimeric (
We first verified that cysteine could be misincorporated at specific
amino acid positions by expressing TIM in the presence or absence of a
series of cysteine misincorporator tRNAs. Cleavage of TIM by NTCB is
observed only when TIM is co-expressed with a misincorporator tRNA
(Fig. 2a). The observed ladder
of cleavage bands depends on the anti-codon sequence of the tRNA and
corresponds to the pattern expected based on the amino acid sequence of
TIM (Fig. 2a). Amino acid analysis confirmed the presence of
low levels of cysteine (~0.3 cysteines/protein) in the purified
proteins. Treatment of the protein with 10 mM iodoacetamide
for 2 min under denaturing conditions completely blocked cleavage at
misincorporated cysteines (Fig. 2b). However, treatment of
the protein with iodoacetamide under native conditions did not block
cleavage at most sites. The data suggest that protein structure
protects these residues from alkylation.
Mapping Binding Sites--
Strategies for chemically
mapping protein interaction sites fall into three broad
categories: interference, cross-linking, and protection (20).
Interference is based on scanning mutagenesis of a protein. If a
residue substitution interferes with a physical interaction,
it is inferred that the residue plays a role in binding. In the
chemical cross-linking approach, residues that participate in
cross-links are identified, and the existence of the cross-link implies
spatial proximity to the binding partner. Finally, protection methods
are based on chemical modification of a protein in the presence and
absence of a binding partner. Binding sites are identified as residues
protected from modification by the presence of the partner. The three
techniques provide distinct and complementary information. For
example, protection and interference experiments identify regions of a
protein that undergo a conformational change upon binding,
whereas cross-linking only maps direct contact surfaces. Each of the
chemical mapping techniques can be carried out in conjunction with
parallel misincorporation of cysteine residues. Because the protection
strategy is most general with respect to multiple proteins and multiple
binding partners, we describe a protection experiment here.
To footprint the ligand-binding site of triosephosphate isomerase, TIM
protein with misincorporated cysteines was alkylated with 10 mM iodoacetamide for 2 min in the presence and
absence of 50 mM glyceraldehyde-3-phosphate, its
substrate. Binding of substrate was found to specifically
protect a subset of the fastest alkylating residue positions (Fig.
3a). Three of these are
located in close proximity to the crystallographically
determined substrate-binding site (Fig. 3b) and correspond
to the only solvent-accessible (less than 99% buried) valine and
leucine residues within 15 Å of the substrate. A fourth residue
protected by the substrate is located in the dimerization loop, which
makes contacts to the substrate in the opposite monomer.
We also investigated the utility of MPAX for mapping a
protein-protein interaction surface. Because native
triosephosphate isomerase is a homodimer that does not interact
with other protein partners, we created tagged variants of TIM with Myc
epitope insertions before or after the fifth helix of the barrel. We
were not able to refold either tagged protein, so the antibody binding
experiment was performed with denatured TIM. Anti-Myc antibodies
specifically protected from alkylation only cysteine residues
misincorporated within the Myc epitope, providing a direct mapping of
the antibody-binding site (Fig. 4).
Alkylation at single amino acid resolution was observed by separating
leucine and isoleucine bands in different gel lanes. The data
demonstrate the utility of MPAX for examining partially folded
proteins. Importantly, a protein-binding interface was revealed in a
single experiment.
Mapping the Protein Surface--
Current de novo
protein structure prediction algorithms yield multiple reasonable
structural models given an input sequence. The inclusion of sparse
experimental NMR data in the prediction process significantly improves
the accuracy and convergence of the computed models (21). To address
the possibility that MPAX data might also be useful for guiding
computational structure prediction, we investigated whether MPAX could
be used to map a protein surface.
The alkylation rates of cysteine residues misincorporated at 61 positions in the TIM sequence were measured. Solvent-exposed residues
are expected to alkylate more rapidly than buried residues, and thus
alkylation rates should be useful for assigning sequence positions to
interior or exterior environments. The observed alkylation rates can be
interpreted using a kinetic model derived from hydrogen exchange
experiments (22). In this model, the solvent accessibility of each
cysteine side chain is described by an equilibrium between unfolded,
solvent-accessible states and a folded, solvent-inaccessible state
(Fig. 1c). Alkylation is assumed to occur only in the
exposed states. The factor by which native protein structure slows
alkylation of a cysteine residue (relative to the rate of alkylation of
the same cysteine in the unfolded state) defines a protection factor for the site of misincorporation. Large protection factors indicate side chain burial, and the magnitude of protection increases in proportion to local protein stability.
Protection factors were measured by incubating TIM for 24 h under
native conditions in the presence of 10 mM iodoacetamide. The samples were withdrawn periodically and analyzed by NTCB cleavage. This procedure allows accurate measurement of rates up to
104-fold slower than the intrinsic alkylation rate (a
protection factor of 104). All of the side chains at sites
displaying a protection factor greater than 103 are more
than 94% buried in the crystal structure of the wild-type protein
(Fig. 5, b and c).
Conversely, all side chains at sites displaying protection factors less
than 10 are at least 30% solvent-accessible. The correlation between
residue burial and protection shows that MPAX can be used to assign
amino acid positions to the interior or exterior of a protein,
providing a constraint on the topology of the protein backbone
fold.
Measuring Protein Stability--
The equilibrium stability of TIM
cannot be measured by spectroscopic methods because even moderate
concentrations of the unfolded polypeptide aggregate.
However, protection factors can provide a direct measure of protein
stability under native conditions, when >99% of the protein is
folded.2 Protection factors
for all of the buried probes were measured at various denaturant
concentrations (data not shown). The denaturant dependence of the
protection factor for the cysteine misincorporated at valine 91, one of
the slowest exchanging residues in TIM, indicates that this cysteine
mutant of TIM is 8.5 kcal mol Misincorporation at Alternate Codons--
For MPAX to be most
broadly applicable, misincorporation at a variety of amino acids is
required. Accordingly, the efficiency of misincorporation by 18 anti-codon mutants of the cysteine tRNA was investigated. The observed
misincorporation levels varied over a fairly narrow range (Table
I), with the differences probably reflecting proofreading activity of the cysteinyl tRNA synthetase. Only
the tRNA complementary to the serine codon AGC caused an obvious
impairment in cell growth. Misincorporation appears to follow normal
wobble base pairing rules (23). For example, the Val(GAC) tRNA
misincorporated cysteine equally well at GUC or GUU codons, but not at
GUG or GUA codons (data not shown).
To expand the number of amino acids to which MPAX can be applied, we
increased the misincorporation efficiency at serine and histidine
codons using a genetic selection described previously (7). The
selection is based on expression of the H. pylori amidase
AmiE in E. coli. AmiE function is required for growth of
E. coli with acetamide as the sole nitrogen source. Mutation of the essential catalytic residue Cys165 in AmiE
eliminates enzymatic function (24). Therefore, efficient misincorporation by the appropriate misincorporator tRNA construct is
required to restore the function of Cys165 mutants. For our
studies, Cys165 was mutated to histidine or serine and
co-transformed into E. coli with mutant misincorporator
libraries. The variants were isolated from the library based on an
increased growth rate in amine-free, acetamide-containing medium. By
direct biochemical measurement, some of these variants exhibit
significantly higher levels of misincorporation (Fig.
6 and Table I). Isolation of mutants that efficiently misincorporate
cysteine for serine and histidine residues suggests that it will be
possible to select efficient misincorporator constructs for all 19 amino acids.
Mass Spectrometry Analysis--
Although it is convenient to
analyze MPAX data by SDS-PAGE, the gel read-out requires that the
protein of interest be devoid of native cysteine residues. A native
cysteine residue is present in 100% of the protein molecules and will
always be cleaved by NTCB. Thus, only misincorporated cysteines located
between the radioactive end label and the closest native cysteine
residue are expected to produce observable cleavage bands. To overcome this limitation, we have developed a mass spectrometry method to
measure the rate of alkylation at misincorporated cysteines. Our
approach is based on a pulse-chase experiment that uses two ICAT
reagents, N-iodoacetyl,
p-chlorobenzyl-12C6-glucamine
(12C-ICAT) and N-iodoacetyl,
p-chlorobenzyl-13C6-glucamine
(13C-ICAT). Except for the difference in nuclear isotope
composition, the two compounds are chemically identical. The protein is
incubated for a variable time under native conditions with
13C-ICAT, followed by incubation under denaturing
conditions with an excess of 12C-ICAT (Fig.
7a). Solvent-exposed cysteines
are modified completely by 13C-ICAT during the initial
pulse, whereas buried cysteines are only alkylated with
12C-ICAT upon unfolding of the protein in the chase step.
After alkylation, the protein is fragmented by proteolysis, and
peptides containing alkylated cysteine residues are purified by
boronate affinity chromatography. This affinity step takes advantage of the fact that the vicinal diols present in the glucose moiety of the
ICAT reagent bind to immobilized boronate groups (25). The purified
peptides are separated by reverse-phase chromatography and analyzed by
mass spectrometry. Each peptide is identified by its absolute mass and
by its mass fragmentation pattern. The 13C-ICAT:12C-ICAT isotope ratio reports the
fractional alkylation of the peptide during the initial alkylation
pulse (Fig. 7, b-d). Thus, the mass isotope ratios for
cysteine-containing peptides provide a quantitative and site-specific
measure of alkylation rates in the folded protein.
We demonstrate the use of the ICAT approach in measuring protection
factors of misincorporated cysteines in the wild-type (cysteine-containing) TIM protein. Protection factors determined by
mass spectrometry are in excellent agreement with those determined by
gel methods (Fig. 7f). Mass spectrometry provides a high
throughput read-out that does not require the removal of native
cysteines from the protein. The ICAT detection method and the modular
design of the misincorporation plasmids are well suited for
proteome-wide studies.
We present a novel technique, MPAX, for the study of protein
structure at single amino acid resolution. First, using cysteine tRNAs
mutated at the anti-codon triplet, we show that we can biosynthetically misincorporate cysteine at specific amino acid sites in a bacterially expressed protein. Second, we use the pool of cysteine-misincorporated protein to map binding sites on the protein for ligands with
Kd values ranging from millimolar
(glyceraldehyde 3-phosphate binding to the TIM active site)
to nanomolar (a polyclonal antibody binding to its epitope).
For cysteine probes whose alkylation is completely blocked
by ligand binding, probe protection increases by a factor of 1 + [ligand]/Kd in the presence of the ligand
relative to its absence. Thus, in principle, MPAX could be used to
determine Kd values for ligands. Third, we identify
amino acids on the protein surface and buried in the protein structure
using MPAX data. This type of information should be useful in
predicting the structures of novel proteins. Fourth, we demonstrate
that MPAX can be used to measure the protein stability of TIM under conditions that favor the native state. TIM does not reversibly unfold
and refold under the conditions conventionally used for stability
measurements. Our data suggest that MPAX will be useful for making
stability measurements on other large proteins that do not exhibit
reversible refolding reactions. Fifth, we show that efficient
misincorporation can be achieved at new codons by application of a
simple bacterial selection scheme. Thus, it should be possible to apply
the MPAX technique to all 20 amino acids. Finally, we demonstrate that
MPAX data can be collected for proteins that contain native cysteine
residues by using a pulse-chase experiment with an isotope-coded
affinity tag detected by mass spectrometry. This approach should be
useful for proteomics work.
Structural Perturbations by Cysteine Mutations--
A concern
regarding the use of misincorporated cysteines as a probe of protein
structure is that a cysteine mutation itself could disrupt the native
conformation. This concern is mitigated by the fact that the cysteine
side chain is small and amphiphilic and thus a good substitute for many
amino acids. To address the question directly, we measured the effects
on in vivo folding caused by cysteine replacements at the
isoleucine, leucine, and valine residues of triosephosphate isomerase.
TIM was expressed in the presence of misincorporator tRNAs and was
purified from both soluble and inclusion body fractions of E. coli. The level of misincorporation at each position was
measured by NTCB cleavage. The cleavage intensity of each residue
in the two protein preparations was found to differ by no more than
5-fold at any position (data not shown). None of the cysteine mutations
causes a significant partitioning of triosephosphate isomerase into
inclusion bodies in vivo, hence cysteine mutations at these
positions do not appear to interfere substantially with folding.
If a cysteine mutation at a buried position did disrupt the protein
structure, the residue would likely be incorrectly classified as
solvent-exposed. This type of disruption is not observed to occur in
the TIM mutants that we studied. All of the residues show protection
factors consistent with their solvent accessibility (Fig. 5,
b and c). Alternatively, cysteine substitution in
a binding interface could interfere with binding. This would produce a
false negative result in a protection experiment, because no protection of the misincorporated cysteine would be observed upon addition of the
binding partner. Again, this phenomenon is not observed in the TIM
mutants we studied. All isoleucine, leucine, and valine residues
involved in the binding sites of both a small molecule and an antibody
are identified correctly (Figs. 3b and 4). Disruption of a
binding interface should never produce a false positive result.
Comparison with Alternative Structural Approaches--
MPAX is
complementary to structural techniques such as x-ray crystallography
and multi-dimensional NMR, because it can provide information on the
dynamical behavior of proteins in complex solutions. Clearly, prior
knowledge of the protein structure greatly facilitates the
interpretation of MPAX data. MPAX is closely related to the amide
proton-deuterium exchange technique, and essentially any type of amide
proton-deuterium exchange experiment can be adapted to the MPAX format.
A disadvantage of MPAX relative to amide proton-deuterium exchange is
that cysteine mutations are expected to perturb protein structure to a
greater extent than proton-deuteron substitutions. MPAX has the
advantage relative to amide proton-deuterium exchange in that it is
read out by gel methods or by mass spectrometry rather than by magnetic
resonance. Thus, the MPAX technique overcomes the technical challenge
of assigning a protein NMR spectrum, the requirement for specialized
equipment, and the protein size limitations inherent to magnetic
resonance. Finally, a number of analytical techniques are based on
introduction of single cysteine substitutions into a protein by
site-directed mutagenesis. Most of these approaches can be accomplished
in the MPAX format, with the advantage that cysteine misincorporation
provides a high throughput means to generate distributed cysteine probes.
Prospectus--
MPAX can be applied to many types of experiments
beyond those demonstrated here. For example, time-resolved measurements
of cysteine reactivity can be used to monitor the kinetic progression of biochemical events (see Ref. 26 for analysis of E. coli
DNA polymerase III processivity clamp assembly by the clamp loader machine and Ref. 27 for studies of apomyoglobin refolding at millisecond resolution). Alkylation of misincorporated cysteines in vivo would probe protein interactions in their natural
environment. Presumably, the technique can be adapted to eukaryotic
expression systems known to accommodate suppressor tRNAs (28, 29).
Taken together, these approaches will make possible detailed structural investigations of complex and formerly inaccessible biological processes.
/
)8 barrel, accurately determining its
substrate-binding site, a protein-protein interaction surface, the
solvent-accessible protein surface, and the stability of the barrel.
Because MPAX requires only microgram quantities of material and is not
limited by protein size, it is ideally suited for proteins not amenable
to conventional structural methods, such as membrane proteins,
partially folded or insoluble proteins, and large protein complexes.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (20K):
[in a new window]
Fig. 1.
Misincorporation proton-alkyl exchange.
a, a cysteine tRNA with the valine anti-codon GAC competes
with native valine tRNAs in the cell. In this example, cysteine is
misincorporated in place of valine at a low level, resulting in an
ensemble of proteins containing single cysteine substitutions.
b, misincorporated cysteines can be used as probes of
solvent accessibility. Exposed cysteines on the protein surface react
with the alkylating reagent R-X to generate an alkylated sulfhydryl
group. These alkylated cysteines do not promote backbone cleavage when
exposed to the cysteine-specific cutting reagent NTCB. Cysteines
protected from solvent by protein-protein interactions or ligand
binding are not alkylated and do promote backbone cleavage when exposed
to NTCB. Cleavage fragments are visualized by gel electrophoresis.
c, changes in cysteine exposure that result from local
protein unfolding or a conformational change can also be
detected.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-D-galactopyranoside to 1 mM.
-33P]ATP and protein kinase A (Sigma). Alkylation of
cysteines was accomplished by incubating the protein in 50 mM sodium bicine, pH 8.6, 10 mM iodoacetamide
for 2 min at room temperature. The reaction was quenched by the
addition of an equal volume of 20 mM
-mercaptoethanol,
0.1 mg/ml bovine serum albumin. NTCB cleavage at cysteine residues was
performed as described (8, 12) with several modifications. An equal
volume of 8 M guanidinium chloride, 300 mM
sodium bicine, pH 8.6, 100 mM NTCB was added to the protein sample and incubated for 5 min. The cyanylated proteins were
trichloroacetic acid-precipitated (13), and the pellet was resuspended
in 10 µl of 8 M urea, 0.1 M
NH4OH. After a 1-h incubation, 5 µl of 500 mM
Tris chloride, pH 6.5, 25% glycerol, 5% SDS, 0.001% Coomassie Brilliant Blue G250 was added to quench the cleavage, and the resulting solution was loaded onto a Tricine gel (14) with an additional comb gel layer (15). This protocol resulted in an average
cleavage efficiency of 84%. Molecular weight markers were constructed
by creating a series of single cysteine mutants of TIM by Kunkel
mutagenesis. The pooled proteins were cleaved with NTCB to generate a
ladder of defined peptides. The gels were run at 140-160 volts
overnight, transferred onto Whatman 3MM Chr paper, and dried. The
gels were exposed on image plates and quantitated on a
PhosphorImager (Molecular Dynamics, Sunnyvale, CA).
20 °C. The
protection factor at each position was defined as the ratio of the
observed rate of alkylation in the unfolded state to the observed rate
of alkylation in the folded protein. The results are the averages of
three independent measurements. Alkylation rates in the
unfolded state were measured to be 3.3 ± 0.1 M
1 s
1 in 4 M GdmCl,
50 mM sodium bicine, pH 8.6, 25 °C for all probes. This
value was corrected to 1.5 M
1
s
1 for denaturant-free buffer based on the effect of
GdmCl on the alkylation rate of glutathione. The fractional burial of
each side chain was calculated using X-PLOR (18) and the 7TIM
structure. To determine the stability of TIM, labeled protein at a
final concentration of 2 µM was incubated with 50 mM sodium bicine, pH 8.6, 10 mM iodoacetamide
for 5 h in the presence of 0.7-1.1 M GdmCl (in 0.1 M increments). The values of RT*ln(protection factor) for
valine 91 were plotted against denaturant concentration and
extrapolated linearly to zero. The unfolding free energy of TIM was
evaluated as the y intercept.
-D-galactopyranoside, 50 µg/ml
ampicillin, and 20 µg/ml kanamycin) were isolated, co-transformed with pH6_TIM_PKA, and screened for misincorporation efficiency.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
/
)8 barrel protein. The TIM
construct used here includes a C-terminal protein kinase A tag to allow
labeling with radioactive phosphate, and an N-terminal His6
tag on a 30-amino acid linker for purification. This linker shifts the
full-length, 290-residue protein away from the fainter cleavage
products during gel electrophoresis.

View larger version (32K):
[in a new window]
Fig. 2.
Specific cysteine misincorporation.
a, TIM was expressed in the presence of the indicated
misincorporator tRNA and labeled at its C terminus with radioactive
phosphate. The labeled protein was then cleaved with NTCB. The expected
pattern of cleavage is shown as black lines to the
left of each lane. MW denotes the
molecular weight markers, which are labeled according to the residue
cleaved in the TIM protein. The position of the full-length protein is
designated as TIM. b, TIM with cysteine
misincorporated at valine positions was treated with 10 mM
iodoacetamide (IA) for 2 min in the presence or absence of 4 M GdmCl and cleaved with NTCB.

View larger version (35K):
[in a new window]
Fig. 3.
Mapping ligand binding. a,
TIM protein was treated with 10 mM iodoacetamide
(IA) for 2 min in the presence (lanes 3 and
6) or absence (lanes 2 and 5) of 50 mM glyceraldehyde-3-phosphate. The protein was then
cleaved with NTCB. The Km of TIM for
glyceraldehyde-3-phosphate is 0.5 mM (30). Unalkylated
protein (lanes 1 and 4) is shown for comparison.
b, the locations of amino acids protected from alkylation by
glyceraldehyde-3-phosphate are illustrated in the yeast TIM crystal
structure. The positions protected by the substrate are shown as
red van der Waals' surfaces, whereas those that show no
protection are shown in gray. The substrate analog is shown
as a green van der Waals' surface.

View larger version (71K):
[in a new window]
Fig. 4.
Mapping a protein-protein interaction. A
Myc epitope tag sequence was inserted into loop 5 of TIM (shown at
right). The tagged protein was treated with 10 mM iodoacetamide (IA) for 2 min in the presence
(lanes 3 and 6) or absence (lanes 2 and 5) of polyclonal rabbit serum inoculated against the Myc
tag (
-myc). The protein was then cleaved with NTCB.
Unalkylated protein (lanes 1 and 4) is shown for
comparison. The three protected bands correspond to the leucine and
isoleucine residues present in the epitope sequence.

View larger version (28K):
[in a new window]
Fig. 5.
Mapping solvent accessibility and
stability. The extent to which protein structure slows the rate of
alkylation at 61 positions in TIM is shown. a, TIM was
alkylated with 10 mM iodoacetamide for variable time
periods and then cleaved with NTCB. Representative data show the
fractional cleavage at three valine positions (substituted by cysteine)
with respect to alkylation time. The solid lines represent
an exponential fit of the data to a first order kinetic model. The
half-life for each fit is indicated. b, the protection
factor at each misincorporation site is plotted against the fractional
burial of the corresponding wild-type residue in the TIM crystal
structure. 35 of the 61 probes examined exhibit protection factors of
104 or greater (the limit of detection in this experiment)
and overlap in the upper right-hand corner of the plot. The
data are shown for the isoleucine (
), valine (
), and leucine
(
) positions. c, residues in the crystal structure of
yeast TIM are colored according to their protection factor. Residues
with a protection factor less than 100 are red, whereas
residues with protection factors greater than 100 are blue.
The highly protected, apparently solvent-exposed residue at the top of
the protein (right) is buried in the dimer interface.
d, the unfolding free energy of the V91C TIM protein
(calculated as RT*ln(protection factor)) is plotted as a function of
GdmCl concentration. The solid line is a linear fit of the
data extrapolated to zero denaturant.
1 stable at 2 µM concentration (Fig. 5d). MPAX allows
measurement of thermodynamic quantities for large and poorly folding
proteins like TIM, permitting the kind of energetic analysis currently restricted to small proteins.
Misincorporation efficiency at different codons

View larger version (58K):
[in a new window]
Fig. 6.
Selection for improved misincorporation.
The misincorporation induced by genetically selected misincorporator
tRNAs (designated by asterisks) is compared with the
misincorporation induced by the original histidine misincorporator
tRNA. The parent serine misincorporator is not shown because it is
toxic in BL21(DE3) cells. The expected cleavage pattern is shown as
black lines to the left of each
lane.

View larger version (28K):
[in a new window]
Fig. 7.
Measuring alkylation by mass
spectrometry. a, the ensemble of
cysteine-misincorporated proteins is alkylated for a variable time
under native conditions with 13C-ICAT. Excess
12C-ICAT in 4 M GdmCl is subsequently added.
The proteins are digested with trypsin, and peptides containing an
alkylated cysteine are purified by affinity chromatography over
polyacrylamide boronate resin. The purified peptides are analyzed by
reverse-phase liquid chromatography coupled with mass spectrometry
(LC-MS). The peptides are identified by their absolute mass
and by their fragmentation pattern. The
13C-ICAT:12C-ICAT ratio at each misincorporated
cysteine determines the fractional alkylation that occurred during the
initial alkylation pulse. b, control experiment showing the
mass spectrum of a 1:1 mixture of 12C-ICAT and
13C-ICAT modified TIM peptide 139-145 (TLDVVER) containing
cysteine misincorporated at Leu140. The calculated masses
for the peptide (H+-TCXDVVER), where the superior
X indicates modification with either the
12C-ICAT or 13C-ICAT reagent are 1166.6 and
1172.6 Da, respectively. The additional peaks at +1, +2, and +3 mass
units correspond to naturally occurring chlorine isotopes that were
used to aid peak identification. c, mass chromatograms for
the control experiment in b. The abundance of peptides with
mass 1166-1167 (upper panel) or 1172-1173 (lower
panel) is plotted versus elution time from a
reverse-phase C18 column. The arrowhead indicates the time
that the mass spectrum shown in b was taken. d,
mass spectrum of the modified TIM peptide 139-145 (TLDVVER) prepared
according to the scheme in a with
= 10 min.
e, mass chromatograms for the experiment shown in
d. The abundance of peptides with mass 1166-1167
(upper panel) or 1172-1173 (lower panel) is
plotted versus elution time from a reverse-phase C18 column.
The arrowhead indicates the time that the mass spectrum
shown in d was taken. The cysteine misincorporated at
position 140 is completely alkylated by 13C-ICAT in the
initial alkylation pulse. The side chain of Leu140 is 40%
solvent accessible in the native structure. f, plot of the
protection factors measured by mass spectrometry read-out
versus those measured by gel read-out. The data are shown
for nine leucine positions and the two naturally occurring cysteines.
Seven data points overlap at the limit of resolution (104)
in the upper right-hand corner of the plot. The root mean
square difference between the logarithms of the protection factors
measured by the two methods is 0.15.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
| |
ACKNOWLEDGEMENTS |
|---|
Anti-Myc serum and H. pylori genomic DNA were the generous gifts of S. Pfeffer and N. Salama, respectively. We thank A. Chien for performing the mass spectrometry analysis and for helpful discussions. We also thank R. Baldwin, S. Nautiyal, S. Pfeffer, D. Herschlag, and members of the Harbury lab for criticism and advice throughout the course of this work.
| |
FOOTNOTES |
|---|
* This work was supported by a grant from the Chicago Community Trust (to P. B. H.) and a Terman fellowship (to P. B. H.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Supported by the Paul and Mildred Berg Stanford Graduate Fellowship.
§ To whom correspondence should be addressed: Dept. of Biochemistry, Stanford University, 279 Campus Dr. W., Stanford, CA 94305. E-mail: harbury@cmgm.stanford.edu.
Published, JBC Papers in Press, May 25, 2002, DOI 10.1074/jbc.M203172200
2 The protection factor is equal to the equilibrium constant between folded and unfolded states when the rate of conformational closing is much faster than the rate of alkylation, a kinetic regime called EX2 (22). All of the alkylation rates were found to depend on the concentration of alkylating reagent, confirming that alkylation occurs by the EX2 mechanism.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: MPAX, misincorporation proton-alkyl exchange; GdmCl, guanidinium chloride; ICAT, isotope coded affinity tag; NTCB, 2-nitro-5-thiocyanobenzoic acid; TIM, triosephosphate isomerase; Tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Galas, D. J.,
and Schmitz, A.
(1978)
Nucleic Acids Res.
5,
3157-3170 |
| 2. | Doonan, S., and Fahmy, H. M. (1975) Eur. J. Biochem. 56, 421-426[Medline] [Order article via Infotrieve] |
| 3. |
Hanai, R.,
and Wang, J. C.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
11904-11908 |
| 4. |
de Arruda, M. V.,
Bazari, H.,
Wallek, M.,
and Matsudaira, P.
(1992)
J. Biol. Chem.
267,
13079-13085 |
| 5. | Doering, D. S., and Matsudaira, P. (1996) Biochemistry 35, 12677-12685[CrossRef][Medline] [Order article via Infotrieve] |
| 6. |
Tu, B. P.,
and Wang, J. C.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
4862-4867 |
| 7. |
Doring, V.,
and Marliere, P.
(1998)
Genetics
150,
543-551 |
| 8. |
Jacobson, G. R.,
Schaffer, M. H.,
Stark, G. R.,
and Vanaman, T. C.
(1973)
J. Biol. Chem.
248,
6583-6591 |
| 9. | Kunkel, T. A., Bebenek, K., and McClary, J. (1991) Methods Enzymol. 204, 125-139[Medline] [Order article via Infotrieve] |
| 10. |
Silverman, J. A.,
Balakrishnan, R.,
and Harbury, P. B.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
3092-3097 |
| 11. | Ausubel, F. M., Brent, R., Kingston, R., Moore, D. D., Seidman, J. G., Smith, J. A., Struhl, K., Albright, L. M., Coen, D. M., and Varki, A. (1995) in Current Protocols in Molecular Biology (Janssen, K., ed), Vol. 1 , p. 11, John Wiley & Sons, New York |
| 12. | Wu, J., and Watson, J. T. (1998) Anal. Biochem. 258, 268-276[CrossRef][Medline] [Order article via Infotrieve] |
| 13. | Arnold, U., and Ulbrich-Hofmann, R. (1999) Anal. Biochem. 271, 197-199[CrossRef][Medline] [Order article via Infotrieve] |
| 14. | Schagger, H., and von Jagow, G. (1987) Anal. Biochem. 166, 368-379[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | Wiltfang, J., Arold, N., and Neuhoff, V. (1991) Electrophoresis 12, 352-366[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Kraulis, P. J. (1991) J. Appl. Crystallogr. 24, 946-950[CrossRef] |
| 17. | Davenport, R. C., Bash, P. A., Seaton, B. A., Karplus, M., Petsko, G. A., and Ringe, D. (1991) Biochemistry 30, 5821-5826[CrossRef][Medline] [Order article via Infotrieve] |
| 18. | Brunger, A. (1992) X-PLOR , Yale University Press, New Haven, CT |
| 19. | Gygi, S. P., Rist, B., Gerber, S. A., Turecek, F., Gelb, M. H., and Aebersold, R. (1999) Nat. Biotechnol. 17, 994-999[CrossRef][Medline] [Order article via Infotrieve] |
| 20. | Creighton, T. E. (1993) Proteins , 2nd Ed. , pp. 333-334, W. H. Freeman and Company, New York |
| 21. | Bowers, P. M., Strauss, C. E. M., and Baker, D. (2000) J. Biomol. NMR 18, 311-318[CrossRef][Medline] [Order article via Infotrieve] |
| 22. |
Bai, Y.,
Sosnick, T. R.,
Mayne, L.,
and Englander, S. W.
(1995)
Science
269,
192-197 |
| 23. | Stryer, L. (1996) Biochemistry , 4 Ed. , pp. 886-888, W. H. Freeman and Company, New York |
| 24. | Kobayashi, M., Yanaka, N., Nagasawa, T., and Yamada, H. (1992) Biochemistry 31, 9000-9007[CrossRef][Medline] [Order article via Infotrieve] |
| 25. | Liu, X. C., and Scouten, pp. 886-888, W. H. (2000) Methods Mol. Biol. 147, 119-128 |
| 26. | Turner, J., Hingorani, M. M., Kelman, Z., and O'Donnell, M. (1999) EMBO J. 18, 771-783[CrossRef][Medline] [Order article via Infotrieve] |
| 27. | Ha, J. H., and Loh, S. N. (1998) Nat. Struct. Biol. 5, 730-737[CrossRef][Medline] [Order article via Infotrieve] |
| 28. |
Laski, F. A.,
Ganguly, S.,
Sharp, P. A.,
RajBhandary, U. L.,
and Rubin, G. M.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
6696-6698 |
| 29. |
Park, H. J.,
and RajBhandary, U. L.
(1998)
Mol. Cell. Biol.
18,
4418-4425 |
| 30. | Hartman, F. C., LaMuraglia, G. M., Tomozawa, Y., and Wolfenden, R. (1975) Biochemistry 14, 5274-5279[CrossRef][Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
S. Mitra, I. V. Shcherbakova, R. B. Altman, M. Brenowitz, and A. Laederach High-throughput single-nucleotide structural mapping by capillary automated footprinting analysis Nucleic Acids Res., June 1, 2008; 36(11): e63 - e63. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Jha and J. B. Udgaonkar Exploring the Cooperativity of the Fast Folding Reaction of a Small Protein Using Pulsed Thiol Labeling and Mass Spectrometry J. Biol. Chem., December 28, 2007; 282(52): 37479 - 37491. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Patel and J. M. Finke Folding and Unfolding of {gamma}TIM Monomers and Dimers Biophys. J., October 1, 2007; 93(7): 2457 - 2471. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Johnson, H.-Y. Tang, C. Carag, D. W. Speicher, and D. E. Discher Forced Unfolding of Proteins Within Cells Science, August 3, 2007; 317(5838): 663 - 666. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||